Study finds sits at the center of this dementia and brain health question.

Yes, research increasingly suggests that recurrent infections are linked to faster memory loss and cognitive decline, particularly in older adults. A landmark 2023 Johns Hopkins study found that people with antibodies to multiple common infections—including cytomegalovirus (CMV), herpes simplex virus type 1 (HSV-1), and COVID-19—showed measurably poorer cognitive performance on memory and thinking tests.

What makes this finding significant is that it’s cumulative: the more infections someone has been exposed to, the greater the association with cognitive problems. For example, an older adult who has had recurrent respiratory infections, herpes reactivation, and COVID-19 may face compounded risk beyond what any single infection would cause. This article explores what the latest research reveals about this connection, which infections carry the highest dementia risk, and what steps people can take to protect their brain health.

What Does Recent Research Reveal About Infections and Cognitive Decline?
Which Infections Pose the Greatest Risk to Brain Health?
How Do Infections Influence Memory Loss and Cognitive Decline?
Are All Age Groups Equally Vulnerable to Infection-Related Cognitive Risk?
What About Past Infections—Should You Be Concerned?
What Steps Can People Take to Protect Brain Health From Infection Risk?
Where Does Research Into Infections and Dementia Go From Here?
Conclusion

What Does Recent Research Reveal About Infections and Cognitive Decline?

The Johns Hopkins Bloomberg School of Public Health study published in 2023 marked the first time researchers demonstrated the cumulative effect of multiple infections on cognitive function. The study measured antibodies to five different common infections in middle-aged and older adults and compared those findings to their performance on standardized cognitive tests. Participants with evidence of exposure to more infections performed significantly worse on tests measuring memory, attention, and processing speed. This wasn’t a single dramatic effect from one infection—it was a steady decline as the infection count increased. However, a critical limitation emerged from UK Biobank research examining younger populations.

Among people ages 40 to 69, midlife infections showed no clear association with accelerated cognitive decline, with one exception: visual memory showed some measurable decline in those with prior infections. This suggests that infection-linked cognitive risk may be much more pronounced in older adults, and that age itself is a crucial variable in how infections affect the brain. The distinction is important for interpretation. The research shows correlation between infections and cognitive problems, not definitive proof that infections directly cause cognitive decline. More longitudinal studies that follow people over many years are needed to establish whether infections accelerate decline or simply co-occur with other aging-related factors. Understanding this nuance helps prevent unnecessary alarm among younger people with past infections while justifying caution in older adults.

What Does Recent Research Reveal About Infections and Cognitive Decline?

Which Infections Pose the Greatest Risk to Brain Health?

Cytomegalovirus (CMV) has emerged as particularly concerning in dementia research. Epidemiological studies show that people with CMV infection carry double the risk of Alzheimer’s disease compared to those without CMV exposure. CMV is a common herpes virus that most people contract during their lifetime and then carry dormant in their bodies. For many people it causes no symptoms, but the virus can reactivate periodically, and this reactivation appears to trigger inflammatory responses that may affect cognitive function over time. HSV-1, another herpes virus that causes cold sores, shows a similarly troubling association with Alzheimer’s disease risk. The risk is particularly pronounced in people who carry the APOE ε4 genetic variant, a known risk factor for Alzheimer’s.

Those with both HSV-1 reactivation and the genetic risk factor face substantially elevated dementia risk—a crucial warning for people who know they carry this genetic variant or have a strong family history of Alzheimer’s. This highlights an important caveat: genetic background matters significantly in determining who faces higher risk from infection exposure. COVID-19 adds a more recent dimension to this concern. Older adults who have had COVID-19 were found to have double the risk of moderate to severe dementia-like impairment compared to younger adults with COVID-19. Age, the severity of the initial infection, and loss of smell during infection emerged as key risk factors. This means an older adult who had severe COVID-19 with olfactory loss faces notably higher cognitive risk than a younger person with mild COVID-19.

How Do Infections Influence Memory Loss and Cognitive Decline?

The precise mechanisms by which infections accelerate cognitive problems aren’t fully mapped, but researchers have identified several plausible pathways. One mechanism involves chronic inflammation triggered by the immune response to persistent or recurring infections. The brain is highly sensitive to inflammatory signals; sustained inflammation can damage neuronal connections and accelerate the death of brain cells involved in memory and learning. When someone has multiple infections over their lifetime, the cumulative inflammatory burden may exceed what the brain’s protective mechanisms can handle. Another pathway involves direct viral effects.

Some viruses, including HSV-1 and CMV, can cross the blood-brain barrier and establish themselves in brain tissue. When these viruses reactivate—sometimes triggered by stress, other infections, or aging—they may directly damage neurons or trigger localized inflammatory responses in the brain. The amyloid plaques and tau tangles characteristic of Alzheimer’s disease may be accelerated by this process, though this remains an area of active investigation. A third consideration involves the microglial activation hypothesis. Microglia are immune cells in the brain that normally maintain brain health, but chronic infection can cause them to become overactive, leading them to damage healthy neurons. This might explain why people with multiple infections show broader cognitive decline rather than isolated memory problems.

How Do Infections Influence Memory Loss and Cognitive Decline?

Are All Age Groups Equally Vulnerable to Infection-Related Cognitive Risk?

Age emerged as the dominant risk factor in COVID-19 dementia research and likely applies to other infections as well. Older adults with COVID-19 had double the dementia risk compared to younger adults, a stark difference that underscores how aging bodies respond differently to infection-related cognitive threats. The aging brain has reduced capacity to clear damaged proteins, mount precise immune responses, and repair inflammatory damage. An older adult’s brain exposed to a severe infection faces far greater jeopardy than a younger person’s brain exposed to the same infection. However, the UK Biobank findings in people ages 40-69 complicate this picture.

These individuals showed no major acceleration of cognitive decline from midlife infections, suggesting that the critical vulnerability window may begin after age 70 or may require decades of infection accumulation before cognitive effects become measurable. This creates a practical distinction: people in midlife likely shouldn’t panic about past infections or current infection risks based on existing evidence, but older adults—particularly those over 70—warrant greater caution. Genetic factors also stratify risk differently across age groups. The APOE ε4 gene variant that amplifies HSV-1 risk is present in only about 25% of the population, yet in those carriers, infection-related cognitive risk may emerge earlier in life than in non-carriers. Knowing your genetic risk profile can help determine how seriously to take infection prevention measures in midlife.

What About Past Infections—Should You Be Concerned?

One of the most anxiety-inducing aspects of infection-dementia research is that most people have already been exposed to these viruses. CMV infection rates exceed 50% in developed countries and far higher in developing nations. HSV-1 affects roughly 70% of people globally. COVID-19 has touched billions. The question becomes: if you’ve already had these infections, is cognitive decline inevitable? The honest answer is no, not necessarily. The research shows association and increased statistical risk, but it does not show that everyone exposed to multiple infections will develop cognitive problems. Many people with histories of recurrent infections maintain sharp minds into old age.

The risk is real but probabilistic, not deterministic. Additionally, the presence of past infections cannot be undone, so worry about them is counterproductive. What matters now is preventing future infections and supporting brain health going forward. This raises an important caveat for older adults specifically. If you’re over 70 and have experienced recurrent infections, particularly severe COVID-19 or reactivated herpes, this is relevant information to share with your healthcare provider. Heightened vigilance about new infections and more aggressive cognitive screening may be warranted. But past infections alone don’t determine your cognitive future—modifiable factors like physical activity, sleep, mental stimulation, and managing cardiovascular health still exert powerful influence over brain aging.

What About Past Infections—Should You Be Concerned?

What Steps Can People Take to Protect Brain Health From Infection Risk?

The clearest protective measure is prevention of future infections, especially in older adults over 70. Updated vaccinations—including annual flu shots, COVID-19 boosters, and pneumococcal vaccines—reduce both infection incidence and severity. For older adults with recurrent herpes infections, antiviral medications like acyclovir can suppress reactivation. Simple hygiene practices like frequent handwashing, respiratory etiquette, and avoiding close contact during infection outbreaks become more important as cognitive risk rises with age. Beyond infection prevention, evidence supports several brain-protective measures that operate somewhat independently of infection risk.

Regular aerobic exercise has robust evidence for slowing cognitive aging and may help counteract inflammatory effects. Mediterranean-style diets rich in antioxidants and omega-3 fatty acids support neuronal health. Cognitive engagement through learning, reading, and social interaction preserves cognitive reserve—the brain’s capacity to maintain function despite pathology. Sleep quality matters substantially for brain health and immune function. These aren’t specific to infection-related cognitive risk, but they represent proven approaches to maintaining cognition in older age.

Where Does Research Into Infections and Dementia Go From Here?

Current research has established correlation between infections and cognitive decline, but the next critical phase involves understanding causation. Researchers need longitudinal studies that track people over decades, measuring infection exposure, immune markers, brain imaging, and cognitive performance in parallel. Such studies might reveal whether preventing infections early in life reduces dementia risk decades later, or whether the damage is primarily done by late-life infections.

Biotech companies are also exploring therapeutics targeting chronic inflammation or viral reactivation, potentially offering new treatment angles if infection-cognitive decline causation is confirmed. The research also highlights the importance of taking infection seriously as a public health issue relevant to brain aging, not just respiratory or immune health. This reframing could shape vaccination campaigns, antiviral access policies, and clinical screening practices for older adults. As evidence accumulates, healthcare providers may increasingly ask older patients about infection history and use that information to inform dementia risk assessment.

Conclusion

The evidence connecting recurring infections to faster memory loss is real but needs appropriate context. Multiple infections—particularly CMV, HSV-1 reactivation, and severe COVID-19—correlate with poorer cognitive performance and elevated dementia risk, especially in older adults. The cumulative effect of multiple infections appears to matter more than any single exposure.

However, this is correlation, not yet proven causation, and many people with extensive infection histories maintain sharp cognition. The practical takeaway is that older adults should prioritize infection prevention through vaccination, good hygiene, and antiviral treatment when appropriate, while simultaneously maintaining other proven brain-protective measures like exercise, cognitive engagement, sleep, and healthy diet. For younger adults, existing evidence doesn’t justify major concern about past infections, though prevention still makes sense. As research continues to clarify how infections influence the aging brain, a clearer picture of risk and prevention will emerge.